Read the Latest ISN Journal Editorial Selections
Kidney International® The ASCEND-NHQ Randomized Trial Found Positive Effects of Daprodustat on Hemoglobin and Quality of Life in Patients With Non-Dialysis Chronic Kidney Disease This clinical trial administered a daily daprodustat or a placebo pill to 614 patients with CKD and anemia for 28 weeks. People treated with daprodustat had a larger increase in hemoglobin and less...